首页 | 本学科首页   官方微博 | 高级检索  
     


Molecular Alterations in Gastric Preneoplastic Lesions and Early Gastric Cancer
Authors:Serena Battista  Maria Raffaella Ambrosio  Francesco Limarzi  Graziana Gallo  Luca Saragoni
Affiliation:1.Pathology Department, “S. Maria della Misericordia Hospital”, Friuli-Venezia Giulia, 33100 Udine, Italy;2.Pathology Department, “Az. USL, Tuscany North-West”, Tuscany, 56121 Pisa, Italy;3.Pathology Department, “G.B. Morgagni-L. Pierantoni Hospital”, Emilia-Romagna, 47121 Forlì, Italy; (F.L.); (L.S.);4.Pathology Department, “M. Bufalini Hospital”, Emilia Romagna, 47521 Cesena, Italy;
Abstract:Prognosis of gastric cancer is dramatically improved by early diagnosis. Correa’s cascade correlates the expression of some molecular markers with the progression of preneoplastic lesions toward carcinoma. This article reviews the diagnostic and prognostic values of molecular markers in complete (MUC2) and incomplete (MUC2, MUC5AC, and MUC6) intestinal metaplasia, gastric dysplasia/intra-epithelial neoplasia, and early gastric cancer. In particular, considering preinvasive neoplasia and early gastric cancer, some studies have demonstrated a correlation between molecular alterations and prognosis, for example, mucins phenotype in gastric dysplasia, and GATA6, TP53 mutation/LOH and MUC6 in early gastric cancer. Moreover, this review considers novelties from the literature regarding the (immuno)histochemical characterization of diffuse-type/signet ring cell gastric cancer, with particular attention to clinical outcomes of patients. The aim of this review is the evaluation of the state of the art regarding suitable biomarkers used in the pre-surgical phase, which can distinguish patients with different prognoses and help decide the best therapeutic strategy.
Keywords:gastric preinvasive neoplasia   early gastric cancer   signet ring cell gastric carcinoma   mucins expression   molecular markers
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号